United States · Who invested in NeuroVia?
NeuroVia's investors include Novartis, Sanofi, Enso Ventures and Sanofi-Genzyme BioVentures/ BioMed.
United States · Series A startup
Who invested in NeuroVia
One round we have observed, with the 4 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$14Mraised across 1 round since 2017, from 1 source
- Latest round
- Series A, $14MJul 2017
- Investors
- 4
The rounds
- Jul 2017Series A$14M
Novartis
Sanofi
Enso Ventures- Sanofi-Genzyme BioVentures/ BioMed
Reported by FinSMEsSEC filing: $14M sold, first sale Nov 2015
Everyone who backed them
Sanofi-Genzyme BioVentures/ BioMedno record of our own yet1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about NeuroVia
How much has NeuroVia raised?
NeuroVia has raised $14M across 1 round since 2017.
When did NeuroVia last raise?
NeuroVia's most recent round was a Series A of $14M in Jul 2017.
What was NeuroVia's biggest round?
Its most recent round, $14M in Jul 2017, is also its largest on record.
Who backed NeuroVia first?
NeuroVia's first round on record, in Jul 2017, was backed by Novartis, Sanofi and Enso Ventures and 1 others.
What stage is NeuroVia at?
NeuroVia's latest named round is a Series A, in Jul 2017.
Where is NeuroVia based?
NeuroVia is based in the United States.
Companies like NeuroVia
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.